PT - JOURNAL ARTICLE AU - Vania Modesto-Lowe AU - Rachel Bojka AU - Camille Alvarado TI - Cannabis for peripheral neuropathy: The good, the bad, and the unknown AID - 10.3949/ccjm.85a.17115 DP - 2018 Dec 01 TA - Cleveland Clinic Journal of Medicine PG - 943--949 VI - 85 IP - 12 4099 - http://www.ccjm.org/content/85/12/943.short 4100 - http://www.ccjm.org/content/85/12/943.full SO - Cleve Clin J Med2018 Dec 01; 85 AB - Cannabis may be an effective alternative or adjunctive treatment for peripheral neuropathy, an often debilitating condition for which standard treatments often provide little relief. Most studies show moderately improved pain from inhaled cannabis use, but adverse effects such as impaired cognition and respiratory problems are common, especially at high doses. Data on the long-term safety of cannabis treatments are limited. Until riskbenefit profiles are better characterized, doctors in states where cannabis therapy is legal should recommend it for peripheral neuropathy only after careful consideration.